Advanced and titanium platelet rich fibrin for treating intrabony defects.

Phase 3

• Registration Number: CTRI/2020/12/029963
• Lead Sponsor: Dr Anjali Gaba

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients having minimum of 20 permanent teeth.

Age group of 20 to 55 years.

Probing pocket depth >= 5mm.

Clinical attachment loss >=3mm.

Radiographic evidence of intrabony defect.

Exclusion Criteria

Systemically compromised patients.

Patients who are on medications that could interfere with wound healing.

Patients with grade III mobility.

Chronic smokers and alcoholics.

Pregnant and lactating females.

Patients who had undergone periodontal treatment with in a period of last 1 year

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
â?¢To evaluate and compare clinical and radiographic outcome of Advanced Platelet - rich fibrin (A-PRF + bone graft) and Titanium Platelet-rich fibrin (T PRF + bone graft) in the treatment of intrabony defect resulting from periodontal disease.Timepoint: 6 months

Secondary Outcome Measures

Name	Time	Method
To evaluate the clinical and radiographic outcome after performing periodontal regenerative therapy with A-PRF <br/ ><br>To evaluate the clinical and radiographic outcome after performing periodontal regenerative therapy with T-PRF <br/ ><br>To compare both the procedures and to find out any possible difference in the two. <br/ ><br>Timepoint: 6 months